PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 128 filers reported holding PTC THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,288,890 | -63.3% | 102,137 | -33.4% | 0.00% | -66.7% |
| Q2 2023 | $6,234,792 | -18.1% | 153,302 | -2.4% | 0.00% | -40.0% |
| Q1 2023 | $7,610,892 | +99168.2% | 157,120 | -21.8% | 0.01% | 0.0% |
| Q4 2022 | $7,667 | -99.9% | 200,877 | -1.7% | 0.01% | -37.5% |
| Q3 2022 | $10,260,000 | +12.7% | 204,388 | -10.1% | 0.01% | +33.3% |
| Q2 2022 | $9,106,000 | +13.5% | 227,297 | +5.7% | 0.01% | +20.0% |
| Q1 2022 | $8,021,000 | -1.3% | 214,974 | +5.4% | 0.01% | 0.0% |
| Q4 2021 | $8,124,000 | +23.9% | 203,974 | +15.8% | 0.01% | +25.0% |
| Q3 2021 | $6,555,000 | -3.4% | 176,156 | +9.8% | 0.00% | 0.0% |
| Q2 2021 | $6,784,000 | -8.4% | 160,485 | +2.6% | 0.00% | -20.0% |
| Q1 2021 | $7,405,000 | -19.2% | 156,388 | +4.2% | 0.01% | -28.6% |
| Q4 2020 | $9,161,000 | +19.3% | 150,106 | -8.6% | 0.01% | 0.0% |
| Q3 2020 | $7,679,000 | -17.7% | 164,248 | -10.6% | 0.01% | -22.2% |
| Q2 2020 | $9,327,000 | +9.8% | 183,815 | -3.5% | 0.01% | -18.2% |
| Q1 2020 | $8,498,000 | -21.6% | 190,486 | -15.6% | 0.01% | 0.0% |
| Q4 2019 | $10,846,000 | +19.8% | 225,810 | -15.6% | 0.01% | +10.0% |
| Q3 2019 | $9,051,000 | -24.9% | 267,623 | -0.0% | 0.01% | -23.1% |
| Q2 2019 | $12,048,000 | +26.4% | 267,728 | +1.1% | 0.01% | +116.7% |
| Q1 2019 | $9,530,000 | +109.7% | 264,878 | +100.0% | 0.01% | 0.0% |
| Q4 2018 | $4,545,000 | -27.7% | 132,439 | -1.0% | 0.01% | -25.0% |
| Q3 2018 | $6,288,000 | +25.2% | 133,796 | -10.1% | 0.01% | +14.3% |
| Q2 2018 | $5,022,000 | +17.6% | 148,900 | -5.7% | 0.01% | +16.7% |
| Q1 2018 | $4,271,000 | +54.6% | 157,835 | -4.7% | 0.01% | +50.0% |
| Q4 2017 | $2,763,000 | -20.2% | 165,658 | -4.3% | 0.00% | -20.0% |
| Q3 2017 | $3,463,000 | +110.8% | 173,045 | +93.0% | 0.01% | +150.0% |
| Q2 2017 | $1,643,000 | +86.3% | 89,642 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $882,000 | -7.9% | 89,642 | +2.0% | 0.00% | -50.0% |
| Q4 2016 | $958,000 | -23.7% | 87,842 | -2.0% | 0.00% | 0.0% |
| Q3 2016 | $1,256,000 | +87.5% | 89,642 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $670,000 | -12.3% | 89,642 | +4.6% | 0.00% | 0.0% |
| Q1 2016 | $764,000 | – | 85,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |